European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.

doi:10.1016/j.ejca.2022.04.018

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.

European journal of cancer (Oxford, England : 1990) - 1 Jul 2022

Garbe Claus, Amaral Teresa, Peris Ketty, Hauschild Axel, Arenberger Petr, Basset-Seguin Nicole, Bastholt Lars, Bataille Veronique, Del Marmol Veronique, Dréno Brigitte, Fargnoli Maria C, Forsea Ana-Maria, Grob Jean-Jacques, Hoeller Christoph, Kaufmann Roland, Kelleners-Smeets Nicole, Lallas Aimilios, Lebbé Celeste, Lytvynenko Bodhan, Malvehy Josep, Moreno-Ramirez David, Nathan Paul, Pellacani Giovanni, Saiag Philippe, Stratigos Alexander J, Van Akkooi Alexander C J, Vieira Ricardo, Zalaudek Iris, Lorigan Paul

Abstract excerpt

A unique collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization of Research and Treatment of Cancer (EORTC) was formed to make recommendations on cutaneous melanoma diagnosis and treatment, based on the systematic literature reviews and the experts' experience. Cutaneous melanomas are excised with one...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Consensus

Share to Melanoma

Share to Melanoma, Cutaneous Malignant

Share to Oximes

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Share to Systematic Reviews as Topic

Source

Open in PubMed

Identifiers

PMID: 35623961
DOI: 10.1016/j.ejca.2022.04.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.PMID 35623961Read ↗

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.Semantic proximity Read ↗

French updated recommendations in Stage I to III melanoma treatment and management.Semantic proximity Read ↗

Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.Semantic proximity Read ↗

Melanoma.Semantic proximity Read ↗

Cutaneous melanoma.Semantic proximity Read ↗

Recognition, Staging, and Management of Melanoma.Semantic proximity Read ↗

The melanoma revolution: from UV carcinogenesis to a new era in therapeutics.Semantic proximity Read ↗

[Guidelines for stage I to III melanoma].Semantic proximity Read ↗

Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma.Semantic proximity Read ↗

Molecular, Genetic Susceptibility and Immunotherapy of MelanomaSemantic proximity Read ↗

Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous MelanomaSemantic proximity Read ↗

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy PredictionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.